Autor: "Akashi K" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Autorzy:: Shirakawa T; Department of Medical Oncology, Fukuoka Wajiro Hospital, 2-2-75 Wajirogaoka, Higashi-Ku, Fukuoka-Shi, Fukuoka, 811-0213, Japan.; Department of Internal Medicine, Karatsu Higashi-Matsuura Medical Association Center, 2566-11 Chiyoda-machi, Karatsu-Shi, Saga, 847-0041, Japan.
Makiyama A; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-Ku, Kitakyushu-Shi, Fukuoka, 806-8501, Japan.; Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu-Shi, Gifu, 501-1194, Japan.
Shimokawa M; Clinical Research Institute, National Kyushu Cancer Center, 3-1-1 Notame, Minami-Ku, Fukuoka-Shi, Fukuoka, 811-1395, Japan.; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube-Shi, Yamaguchi, 755-8505, Japan.
Otsuka T; Department of Medical Oncology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.; Department of Internal Medicine, Minato Medical Clinic, 3-11-3 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-0072, Japan.
Shinohara Y; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-Ku, Kitakyushu-Shi, Fukuoka, 806-8501, Japan.
Koga F; Department of Hepatobiliary and Pancreatology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.
Ueda Y; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, 2-1-1 Nagamine-Minami, Higashi-Ku, Kumamoto-Shi, Kumamoto, 861-8520, Japan.
Nakazawa J; Department of Medical Oncology, Kagoshima City Hospital, 37-1 Uearata-Cho, Kagoshima-Shi, Kagoshima, 890-8760, Japan.
Otsu S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593, Japan.
Komori A; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593, Japan.; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-Machi, Matsuyama-Shi, Ehime, 791-0280, Japan.
Arima S; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-Shi, Kagoshima, 890-8520, Japan.
Fukahori M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume-Shi, Fukuoka, 830-0011, Japan.; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
Taguchi H; Department of Gastroenterology, Saiseikai Sendai Hospital, 2-46 Harada-Cho, Satsumasendai-Shi, Kagoshima, 895-0074, Japan.; Department of Gastroenterology, Kagoshima City Hospital, 37-1 Uearata-Cho, Kagoshima-Shi, Kagoshima, 890-8760, Japan.
Honda T; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki-Shi, Nagasaki, 852-8501, Japan.
Shibuki T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, 860 Ninose-Ko, Arita-Cho, Nishi-Matsuura-Gun, Saga, 849-4193, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanohara, Kashiwa-Shi, Chiba, 277-8577, Japan.
Nio K; Department of Medical Oncology, Sasebo Kyosai Hospital, 10-17 Shimanji-Cho, Sasebo-Shi, Nagasaki, 857-8575, Japan.; Department of Medical Oncology, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-8539, Japan.
Ide Y; Department of Internal Medicine, Karatsu Red Cross Hospital, 2430 Watada, Karatsu-Shi, Saga, 847-8588, Japan.; Department of Internal Medicine, National Hospital Organization Saga Hospital, 1-20-1 Hinode, Saga-Shi, Saga, 849-8577, Japan.
Ureshino N; Department of Medical Oncology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.; Department of Medical Oncology, Kimitsu Chuo Hospital, 1010 Sakurai, Kisarazu-Shi, Chiba, 292-8535, Japan.
Mizuta T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, 860 Ninose-Ko, Arita-Cho, Nishi-Matsuura-Gun, Saga, 849-4193, Japan.; Department of Internal Medicine, Fujikawa Hospital, 1-2-6 Matsubara, Saga-Shi, Saga, 840-0831, Japan.
Mitsugi K; Department of Medical Oncology, Sasebo Kyosai Hospital, 10-17 Shimanji-Cho, Sasebo-Shi, Nagasaki, 857-8575, Japan. .; Department of Medical Oncology, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-8539, Japan. .
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi‑ku, Fukuoka, 812-8582, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi‑ku, Fukuoka, 812-8582, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5311. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Autorzy:: Tsuchihashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ito M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Arita S; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kusaba H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology Organization, Hamanomachi Hospital, Fukuoka, Japan.
Kusano W; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Matsumura T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kitazono T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ueno S; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taguchi R; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshihiro T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Doi Y; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Arimizu K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ohmura H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kajitani T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Nio K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology Organization, Hamanomachi Hospital, Fukuoka, Japan.
Nakano M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Oshima K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Tamura S; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Shirakawa T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Shimokawa H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Hematology and Oncology, Japan Community Health care Organization Kyushu Hospital, Fukuoka, Japan.
Uchino K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Hanamura F; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.; Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
Okumura Y; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Komoda M; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Isobe T; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan.
Ariyama H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Esaki T; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Hashimoto K; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Komune N; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsuo M; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsumoto K; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Asai K; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of radiation therapy, Hamanomachi Hospital, Fukuoka, Japan.
Yoshitake T; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamamoto H; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Oct 31; Vol. 23 (1), pp. 1046. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Head and Neck Neoplasms*/therapy
Rhabdomyosarcoma*/pathology
Adult ; Humans ; Middle Aged ; Japan ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies ; Salvage Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: POT1a deficiency in mesenchymal niches perturbs B-lymphopoiesis.
Autorzy:: Nakashima K; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kunisaki Y; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. .; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan. .; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. .
Hosokawa K; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Gotoh K; Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yao H; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuta R; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Semba Y; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Nogami J; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Kikushige Y; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Stumpf PS; Joint Research Center for Computational Biomedicine, RWTH Aachen University, Aachen, Germany.
MacArthur BD; Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton, UK.; Mathematical Sciences, University of Southampton, Southampton, UK.; The Alan Turing Institute, London, UK.
Kang D; Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Ohga S; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Arai F; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2023 Sep 29; Vol. 6 (1), pp. 996. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphopoiesis*/genetics
Telomere*/genetics
Telomere*/metabolism
Animals ; Mice ; Aging ; Cell Differentiation ; Telomere-Binding Proteins/genetics ; Telomere-Binding Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Autorzy:: Saito S; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Yamada M; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .
Yano R; Department of Nursing, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Takahashi K; Department of Nursing, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ebara A; Department of Nursing, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Sakanaka H; Department of Nursing, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Matsumoto M; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ishimaru T; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Utsuno H; Clinical Laboratory, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Matsuzawa Y; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ooka R; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Fukuoka M; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Akashi K; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Kamijo S; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Hamatani T; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Tanaka M; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2023 Aug 10; Vol. 16 (1), pp. 159. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:: Journal Article
MeSH Terms:: Fertility Preservation*/methods
Neoplasms*/complications
Neoplasms*/drug therapy
Autoimmune Diseases*/therapy
Pregnancy ; Humans ; Female ; Prospective Studies ; Progestins/therapeutic use ; Cryopreservation/methods ; Oocyte Retrieval ; Oocytes ; Live Birth ; Ovulation Induction/methods ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Achievement of sufficient antibody response after a fourth dose of wild-type SARS-CoV-2 mRNA vaccine in nursing home residents.
Autorzy:: Chong Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Goto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Watanabe H; Department of Clinical Immunology, Rheumatology, and Infectious Disease, Kyushu University Hospital, Fukuoka, Japan.
Tani N; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Yonekawa A; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Ikematsu H; Division of Influenza Research, Japan Physicians Association, Tokyo, Japan.
Shimono N; Department of Center for the Study of Global Infection, Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Tanaka Y; Department of Internal Medicine, Medical Corporation SOUSEIKAI, Kanenokuma Hospital, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.; Pokaż więcej
Źródło:: Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Aug; Vol. 11 (8), pp. e962.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19 Vaccines*
COVID-19*/prevention & control
Adult ; Humans ; Aged ; Aged, 80 and over ; Middle Aged ; SARS-CoV-2 ; Antibody Formation ; Nursing Homes ; Immunoglobulin G ; mRNA Vaccines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Autorzy:: Shirakawa T; Department of Medical Oncology, Fukuoka Wajiro Hospital, 2-2-75 Wajirogaoka, Higashi-Ku, Fukuoka-Shi, Fukuoka, 811-0213, Japan.; Department of Internal Medicine, Karatsu Higashi-Matsuura Medical Association Center, 2566-11 Chiyoda-machi, Karatsu-Shi, Saga, 847-0041, Japan.
Makiyama A; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-Ku, Kitakyushu-Shi, Fukuoka, 806-8501, Japan.; Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu-Shi, Gifu, 501-1194, Japan.
Shimokawa M; Clinical Research Institute, National Kyushu Cancer Center, 3-1-1 Notame, Minami-Ku, Fukuoka-Shi, Fukuoka, 811-1395, Japan.; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube-Shi, Yamaguchi, 755-8505, Japan.
Otsuka T; Department of Medical Oncology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.; Department of Internal Medicine, Minato Medical Clinic, 3-11-3 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-0072, Japan.
Shinohara Y; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-Ku, Kitakyushu-Shi, Fukuoka, 806-8501, Japan.
Koga F; Department of Hepatobiliary and Pancreatology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.
Ueda Y; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, 2-1-1 Nagamine-Minami, Higashi-Ku, Kumamoto-Shi, Kumamoto, 861-8520, Japan.
Nakazawa J; Department of Medical Oncology, Kagoshima City Hospital, 37-1 Uearata-Cho, Kagoshima-Shi, Kagoshima, 890-8760, Japan.
Otsu S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593, Japan.
Komori A; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593, Japan.; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-Machi, Matsuyama-Shi, Ehime, 791-0280, Japan.
Arima S; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-Shi, Kagoshima, 890-8520, Japan.
Fukahori M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume-Shi, Fukuoka, 830-0011, Japan.; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
Taguchi H; Department of Gastroenterology, Saiseikai Sendai Hospital, 2-46 Harada-Cho, Satsumasendai-Shi, Kagoshima, 895-0074, Japan.; Department of Gastroenterology, Kagoshima City Hospital, 37-1 Uearata-Cho, Kagoshima-Shi, Kagoshima, 890-8760, Japan.
Honda T; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki-Shi, Nagasaki, 852-8501, Japan.
Shibuki T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, 860 Ninose-Ko, Arita-Cho, Nishi-Matsuura-Gun, Saga, 849-4193, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanohara, Kashiwa-Shi, Chiba, 277-8577, Japan.
Nio K; Department of Medical Oncology, Sasebo Kyosai Hospital, 10-17 Shimanji-Cho, Sasebo-Shi, Nagasaki, 857-8575, Japan.; Department of Medical Oncology, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-8539, Japan.
Ide Y; Department of Internal Medicine, Karatsu Red Cross Hospital, 2430 Watada, Karatsu-Shi, Saga, 847-8588, Japan.; Department of Internal Medicine, National Hospital Organization Saga Hospital, 1-20-1 Hinode, Saga-Shi, Saga, 849-8577, Japan.
Ureshino N; Department of Medical Oncology, Saga-Ken Medical Center Koseikan, 400 Kase-Machi, Saga-Shi, Saga, 840-8571, Japan.; Department of Medical Oncology, Kimitsu Chuo Hospital, 1010 Sakurai, Kisarazu-Shi, Chiba, 292-8535, Japan.
Mizuta T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, 860 Ninose-Ko, Arita-Cho, Nishi-Matsuura-Gun, Saga, 849-4193, Japan.; Department of Internal Medicine, Fujikawa Hospital, 1-2-6 Matsubara, Saga-Shi, Saga, 840-0831, Japan.
Mitsugi K; Department of Medical Oncology, Sasebo Kyosai Hospital, 10-17 Shimanji-Cho, Sasebo-Shi, Nagasaki, 857-8575, Japan. .; Department of Medical Oncology, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-8539, Japan. .
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi‑ku, Fukuoka, 812-8582, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi‑ku, Fukuoka, 812-8582, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 31; Vol. 13 (1), pp. 8815. Date of Electronic Publication: 2023 May 31.
Typ publikacji:: Journal Article
MeSH Terms:: C-Reactive Protein*/analysis
Pancreatic Neoplasms*
Humans ; Gemcitabine ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Albumins ; Prognosis ; Biomarkers ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms.
Autorzy:: Goto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Sasaki T; R&D Department, KAICO Ltd, Fukuoka, Japan.; Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
Chong Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Taniguchi M; R&D Department, KAICO Ltd, Fukuoka, Japan.
Lee JM; Laboratory of Creative Science for Insect Industries Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
Masuda A; Laboratory of Creative Science for Insect Industries Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
Ebihara T; Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
Shiraishi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Tani N; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Yonekawa A; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Gondo K; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.
Kuwano H; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.
Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Ikematsu H; Ricerca Clinica Co., Fukuoka, Japan.
Akashi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Kusakabe T; Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.; Pokaż więcej
Źródło:: Human antibodies [Hum Antibodies] 2023; Vol. 31 (3), pp. 27-33.
Typ publikacji:: Journal Article
MeSH Terms:: Bombyx*
COVID-19*
Humans ; Animals ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Enzyme-Linked Immunosorbent Assay ; Antibodies, Viral ; Immunoglobulin G ; Antibodies, Neutralizing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
Autorzy:: Chong Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Goto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Tani N; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Yonekawa A; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Ikematsu H; Japan Physicians Association, Tokyo, Japan.
Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Tanaka Y; Medical Corporation SOUSEIKAI, Kanenokuma Hospital, Fukuoka, Japan.
Akashi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.; Pokaż więcej
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1066-1071. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
SARS-CoV-2*/genetics
Aged, 80 and over ; Antibodies, Viral ; Antibody Formation ; BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; Immunoglobulin G ; Middle Aged ; Nursing Homes ; RNA, Messenger ; Vaccination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study.
Autorzy:: Nakayama Y; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hashimoto M; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Clinical Immunology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Watanabe R; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Clinical Immunology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Murakami K; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Murata K; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tanaka M; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ito H; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yamamoto W; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Health Information Management, Kurashiki Sweet Hospital, Okayama, Japan.
Ebina K; Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hata K; Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical College, Osaka, Japan.
Hiramatsu Y; Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical College, Osaka, Japan.
Katayama M; Department of Rheumatology, Osaka Red Cross Hospital, Osaka, Japan.
Son Y; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Amuro H; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Akashi K; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Hyogo, Japan.
Onishi A; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Hyogo, Japan.
Hara R; The Center for Rheumatic Diseases, Department of Orthopaedic Surgery, Nara Medical University, Nara, Japan.
Yamamoto K; Department of Medical Informatics, Wakayama Medical University, Wakayama, Japan.
Ohmura K; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Matsuda S; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Morinobu A; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Pokaż więcej
Źródło:: Scandinavian journal of rheumatology [Scand J Rheumatol] 2022 Nov; Vol. 51 (6), pp. 431-440. Date of Electronic Publication: 2021 Sep 13.
Typ publikacji:: Journal Article
MeSH Terms:: Arthritis, Rheumatoid*/drug therapy
Antirheumatic Agents*/therapeutic use
Humans ; Abatacept/therapeutic use ; Cohort Studies ; Tumor Necrosis Factor Inhibitors ; Antibodies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication.
Autorzy:: Tani N; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Ikematsu H; Ricerca Clinica Co, Fukuoka, Japan.
Goto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Gondo K; Clinical Laboratory, Fukuoka City Hospital, Fukuoka, Japan.
Inoue T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Yanagihara Y; Pharmacy, Fukuoka City Hospital, Fukuoka, Japan.
Kurata Y; Pharmacy, Fukuoka City Hospital, Fukuoka, Japan.
Oishi R; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Minami J; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Onozawa K; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Nagano S; Department of Neurology, Fukuoka City Hospital, Fukuoka, Japan.
Kuwano H; Department of Surgery, Fukuoka City Hospital, Fukuoka, Japan.
Akashi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Chong Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2022 Sep 23; Vol. 9 (10), pp. ofac493. Date of Electronic Publication: 2022 Sep 23 (Print Publication: 2022).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
Autorzy:: Goto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Tani N; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Ikematsu H; Ricerca Clinica Co., Fukuoka, Japan.
Gondo K; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.
Oishi R; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Minami J; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Onozawa K; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.; Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.
Kuwano H; COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.
Akashi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Chong Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jul 25; Vol. 17 (7), pp. e0272056. Date of Electronic Publication: 2022 Jul 25 (Print Publication: 2022).
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Cross Infection*/epidemiology
Cross Infection*/prevention & control
Antibodies, Monoclonal, Humanized ; Antibodies, Viral ; BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; Immunoglobulin G ; SARS-CoV-2/genetics ; Vaccination
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Autorzy:: Saiki C; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Kashiwado Y; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Yokoyama T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ayano M; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Imabayashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Kawano S; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Higashioka K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Kimoto Y; Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Oita, Japan.
Fukata M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Mitoma H; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Ono N; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Arinobu Y; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Horiuchi T; Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Oita, Japan.
Niiro H; Department of Medical Education, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Pokaż więcej
Źródło:: Modern rheumatology case reports [Mod Rheumatol Case Rep] 2022 Jun 24; Vol. 6 (2), pp. 183-188.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/etiology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Pulmonary Arterial Hypertension*/etiology
Acetamides ; Adult ; Epoprostenol/therapeutic use ; Female ; Humans ; Iloprost/therapeutic use ; Pyrazines ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Chemical Fingerprinting of Heat Stress Responses in the Leaves of Common Wheat by Fourier Transform Infrared Spectroscopy.
Autorzy:: Osman SOM; United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho-Minami, Tottori 680-0945, Japan.; Agricultural Research Corporation, Wad Medani P.O. Box 126, Sudan.
Saad ASI; Agricultural Research Corporation, Wad Medani P.O. Box 126, Sudan.
Tadano S; United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho-Minami, Tottori 680-0945, Japan.
Takeda Y; Faculty of Agriculture, Tottori University, 4-101 Koyama-Chou-Minami, Tottori 680-0945, Japan.
Konaka T; United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho-Minami, Tottori 680-0945, Japan.
Yamasaki Y; Arid Land Research Center, Tottori University, 1390 Hamasaka, Tottori 680-0001, Japan.
Tahir ISA; Agricultural Research Corporation, Wad Medani P.O. Box 126, Sudan.
Tsujimoto H; Arid Land Research Center, Tottori University, 1390 Hamasaka, Tottori 680-0001, Japan.
Akashi K; United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho-Minami, Tottori 680-0945, Japan.; Faculty of Agriculture, Tottori University, 4-101 Koyama-Chou-Minami, Tottori 680-0945, Japan.; Arid Land Research Center, Tottori University, 1390 Hamasaka, Tottori 680-0001, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Mar 04; Vol. 23 (5). Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Plant Leaves*/chemistry
Triticum*/chemistry
Discriminant Analysis ; Heat-Shock Response ; Spectroscopy, Fourier Transform Infrared/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis.
Autorzy:: Tsuchihashi K; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamaguchi K; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taguchi R; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kohashi K; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ijichi K; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Okumura Y; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakano M; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ohno A; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hioki T; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shimokawa H; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ariyama H; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kusaba H; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Pokaż więcej
Źródło:: Case reports in oncology [Case Rep Oncol] 2022 Feb 07; Vol. 15 (1), pp. 71-77. Date of Electronic Publication: 2022 Feb 07 (Print Publication: 2022).
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer.
Autorzy:: Akashi K; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. akashi.; Department of Otolaryngology and Head and Neck Surgery, Kameda Medical Center, Chiba, Japan. akashi.
Sakai T; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Fukuoka O; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Saito Y; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Yoshida M; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.; Department of Otolaryngology, Showa General Hospital, Tokyo, Japan.
Ando M; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.; Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ito T; Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Murakami Y; Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Yamasoba T; Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Jan 12; Vol. 12 (1), pp. 572. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:: Circulating Tumor DNA/*blood
Neoplasm Recurrence, Local/*blood
Oropharyngeal Neoplasms/*blood
Papillomaviridae/*genetics
Aged ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Case-Control Studies ; Female ; Genes, p16 ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/therapy ; Neoplasm Recurrence, Local/virology ; Oropharyngeal Neoplasms/diagnostic imaging ; Oropharyngeal Neoplasms/therapy ; Oropharyngeal Neoplasms/virology ; Tomography, X-Ray Computed

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: A Japanese patient with anti-PM/Scl and centromere antibody-positive scleroderma-amyopathic dermatomyositis overlap syndrome who developed renal crisis.
Autorzy:: Nishida T; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyusyu, Fukuoka, Japan.; Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Fukuoka, Japan.
Nakano K; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyusyu, Fukuoka, Japan.; Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.
Satoh M; Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyusyu, Fukuoka, Japan.
Fukuyo S; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyusyu, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Fukuoka, Japan.
Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyusyu, Fukuoka, Japan.; Pokaż więcej
Źródło:: Modern rheumatology case reports [Mod Rheumatol Case Rep] 2022 Jan 07; Vol. 6 (1), pp. 69-74.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Dermatomyositis*
Scleroderma, Systemic*/complications
Aged, 80 and over ; Antibodies, Antinuclear ; Centromere ; Female ; Humans ; Japan
SCR Disease Name:: Amyopathic dermatomyositis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Metabolome Profiling of Heat Priming Effects, Senescence, and Acclimation of Bread Wheat Induced by High Temperatures at Different Growth Stages.
Autorzy:: Matsunaga S; United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho Minami, Tottori 680-8553, Japan.
Yamasaki Y; Arid Land Research Center, Tottori University, 1390 Hamasaka, Tottori 680-0001, Japan.
Mega R; Graduate School of Science & Technology for Innovation, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan.
Toda Y; Department of Agricultural and Environmental Biology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo, Tokyo 113-8657, Japan.
Akashi K; Faculty of Agricultural Sciences, Tottori University, 4-101 Koyama-Cho Minami, Tottori 680-8553, Japan.
Tsujimoto H; Arid Land Research Center, Tottori University, 1390 Hamasaka, Tottori 680-0001, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 05; Vol. 22 (23). Date of Electronic Publication: 2021 Dec 05.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers/*metabolism
Metabolomics/*methods
Triticum/*growth & development
Acclimatization ; Hot Temperature ; Proline/metabolism ; Putrescine/metabolism ; Seeds/growth & development ; Seeds/metabolism ; Serotonin/metabolism ; Triticum/metabolism ; Tryptophan/metabolism ; beta-Alanine/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
Autorzy:: Yoshimoto G; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Mori Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Odawara J; Department of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
Kuriyama T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ueno T; Department of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Obara T; Department of Hematology, Japan Community Health Care Organization Kyushu Hospital, KitaKyushu, Japan.
Yurino A; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.
Yoshida S; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ogawa R; Department of Hematology, Japan Community Health Care Organization Kyushu Hospital, KitaKyushu, Japan.
Ohno Y; Department of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Iwasaki H; Department of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2939-2948. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/therapy
Azacitidine/therapeutic use ; Humans ; Retrospective Studies ; Transplantation, Homologous

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study.
Autorzy:: Suetsugu K; Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Muraki S; Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Fukumoto J; Department of Clinical Pharmacology and Biopharmaceutics, The Pharmaceutical College, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Matsukane R; Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Mori Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Hirota T; Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.; Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Egashira N; Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.; Department of Clinical Pharmacology and Biopharmaceutics, The Pharmaceutical College, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Ieiri I; Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .; Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .; Department of Clinical Pharmacology and Biopharmaceutics, The Pharmaceutical College, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .; Pokaż więcej
Źródło:: Drugs in R&D [Drugs R D] 2021 Dec; Vol. 21 (4), pp. 419-429. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Methylprednisolone*
Acetates ; Antifungal Agents ; Humans ; Quinazolines ; Retrospective Studies ; Voriconazole

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
Autorzy:: Shimada E; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Endo M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Matsumoto Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Tsuchihashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Ito M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Kusaba H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nabeshima A; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nawata T; Department of Orthopaedic Surgery, Kyushu Rosai Hospital, 1-1, Sonekita, Kokuraminami-ku, Kitakyushu, Fukuoka 800-0296, Japan.
Maekawa A; Department of Orthopaedic Surgery, Kyushu Rosai Hospital, 1-1, Sonekita, Kokuraminami-ku, Kitakyushu, Fukuoka 800-0296, Japan.
Matsunobu T; Department of Orthopaedic Surgery, Kyushu Rosai Hospital, 1-1, Sonekita, Kokuraminami-ku, Kitakyushu, Fukuoka 800-0296, Japan.
Setsu N; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Fujiwara T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Iida K; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nakagawa M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Hirose T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Kanahori M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Oyama R; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Isobe T; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Ariyama H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Kohashi K; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Yamamoto H; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Iwamoto Y; Department of Orthopaedic Surgery, Kyushu Rosai Hospital, 1-1, Sonekita, Kokuraminami-ku, Kitakyushu, Fukuoka 800-0296, Japan.
Akashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nakashima Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.; Pokaż więcej
Źródło:: Journal of clinical medicine [J Clin Med] 2021 Oct 26; Vol. 10 (21). Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Akashi K"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język